BioPharma APAC - Leading Source of Biopharmaceutical Intelligence in Asia Pacific

Exciva Raises EUR 51 Million Series B To Advance Phase Two Alzheimer’s Agitation Trial

Series B financing will support Exciva's Phase 2 clinical trial of its lead candidate, Deraphan, for agitation associated with Alzheimer's disease (AD) ...

January 21, 2026 | News

Ascletis Selects Once Monthly Triple Agonist ASC37 As Clinical Development Candidate For Obesity

- In head-to-head non-human primate (NHP) studies, average observed half-life of ASC37 was approximately 17 days, 7-fold longer than retatrutide, whic...

January 21, 2026 | News

Docquity Launches Engage To Bring Ai Powered Market Intelligence To HCP Engagement Across Asia

Docquity, a leading health tech company in Asia, announced the launch of Docquity EngageTM, an AI&nb...

January 16, 2026 | News

Ractigen Doses First Patient In Phase Two Trial Of RAG 17 For SOD1 Mutated Als

The initial dosing occurred at Second Affiliated Hospital, Zhejiang University School of Medicine, under the leadership of Dr. Zhi-Ying Wu, head...

January 15, 2026 | News

Animate Biosciences Delivers Ai Designed Peptides That Match Standard Of Care In Pulmonary Fibrosis Model

Animate Biosciences announces positive preclinical results from a mouse model of pulmonary fibrosis demonstrating that two of its AI-designed therapeu...

January 15, 2026 | News

Management of Relapsed/Refractory Multiple Myeloma

Doctors and researchers have made huge steps in treating this blood cancer lately. Yet, most people face a time when the cancer returns or stops responding...

January 14, 2026 | News

China Approves ArkBio Aizhida For ADHD With Rapid Onset And All Day Symptom Control

Shanghai Ark Biopharmaceutical Co., Ltd. ("ArkBio") today announced that China's National Medical Products Administration (NMPA) has approved the...

January 12, 2026 | News

Ventaris Surgical Raises $30 Million Series A To Transform Kidney Stone Surgery

Ventaris Surgical, Inc., a San Carlos, CA-based medical device company developing a next-generation system for kidney stone treatment, announced the ...

January 12, 2026 | News

One Genomics And CiRA Foundation Forge AI Powered Genome Engineering Alliance To Accelerate De Aging Science

AI-Focused Genomics Company Advancing De-Aging Science Collaborates with Leading iPS Cell Manufacturing and Research Foundation One Genomics, an...

January 12, 2026 | News

Thermo Fisher Scientific Enrols First Patient In New CorEvitas Obesity Registry

Thermo Fisher Scientific Inc., the world leader in serving science,announced the enrollment of the first patient in the new PPD™ CorEvitas™ Obe...

January 08, 2026 | News

Shanghai Ark Biopharmaceutical Secures NMPA Approval For Azstarys ADHD Treatment In China

Shanghai Ark Biopharmaceutical Co., Ltd. ("ArkBio") announced that China's National Medical Products Administration (NMPA) has approved the New D...

January 07, 2026 | News

Sisram Medical Clears Final Regulatory Step For DAXXIFY Market Entry In China

Marking a Key Milestone Toward Market Launch and Strengthening Sisram's Premium Aesthetics Portfolio Sisram Medical Ltd (the "Company...

January 06, 2026 | News

CivicaScript Expands Affordable Biosimilar Access With Insulin And Ustekinumab Launches

CivicaScript®, LLC, a nonprofit company dedicated to bringing low-cost generic medicines and biosimilars to U.S. patients, announced the availabi...

January 06, 2026 | News

Leading the Future of Care: Patient Organizations Driving Health System Transformation

Real Change Starts with Listening Across the Asia Pacific, Middle East, and Africa, healthcare systems are facing mounting pressures with rising rates of ...

January 05, 2026 | Opinion | By Sung Lee, Executive Director, Region Communications and Patient Advocacy, Asia Pacific, Middle East, Africa (APMA), Novartis

Stay Connected